Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN known ✓ | P00797 | 1/20 | 0.44 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.44 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.43 |
| ▸ | BCL9 | O00512 | 18/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 18/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL4124161 | 1.00 | BCL9 (0.46) | BCL9CTNNB1RENCYP3A4KCNH2 | |
| Fumaric Acid SCHEMBL4124157 | 1.00 | BCL9 (0.46) | BCL9CTNNB1RENCYP3A4KCNH2 | |
| SCHEMBL4124516 | 0.91 | SLC6A2 (0.47) | BCL9CTNNB1KCNH2 | |
| SCHEMBL4124512 | 0.91 | SLC6A2 (0.47) | BCL9CTNNB1KCNH2 | |
| Fumaric Acid SCHEMBL4131977 | 0.89 | HRH1 (0.47) | BCL9CTNNB1KCNH2HRH1 | |
| Maleic Acid SCHEMBL4131972 | 0.89 | HRH1 (0.47) | BCL9CTNNB1KCNH2HRH1 | |
| Fumaric Acid SCHEMBL4131979 | 0.89 | HRH1 (0.47) | BCL9CTNNB1KCNH2HRH1 | |
| Fumaric Acid SCHEMBL4138352 | 0.86 | HRH1 (0.47) | KCNH2HRH1 | |
| Fumaric Acid SCHEMBL4138360 | 0.86 | HRH1 (0.47) | KCNH2HRH1 | |
| Fumaric Acid SCHEMBL4138362 | 0.86 | HRH1 (0.47) | KCNH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215857-A1 | Therapeutic Pyrrolidines | PFIZER PRODUCTS INC. (US) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215857-A1 | Therapeutic Pyrrolidines | OPRL1, HTR5A, OPRD1 | REN 158/4885KCNH2 673/4885HRH1 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.